The Efficacy and Safety of HIPEC Combined With PD-1 and SOX Chemotherapy for the Translational Treatment of GC or EGJC With PM
Clinical trial NCT06427252 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06427252
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-31
- Primary completion
- 2026-05-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.